|Day Low/High||14.70 / 15.43|
|52 Wk Low/High||11.25 / 27.25|
Sluggish M&A market has actually picked up the pace the deeper it's gone into 2016.
Total's investors are unimpressed by a sale which reduces diversification even if it should boost earnings per share this year.
Long the bastion of the fabulously rich, these firms are no longer letting others do their bidding and are instead directly investing in portfolio companies themselves.
Noble Midstream priced its offering while Yorktown-backed Extraction Oil & Gas filed to go public, following Vantage Energy earlier in the week.
U.S. stock futures rise ahead of a heap of economic data; Apple sells out initial quantities of iPhone 7 plus; federal prosecutors are investigating Wells Fargo, a report says.
U.S. stocks stage a rally Monday, buoyed by comments from the Federal Reserve chief Friday.
Stocks rally as investors continue to analyze Federal Reserve Chair Janet Yellen's Friday speech.
U.S. stocks are rising Monday as investors continue to digest comments from top Federal Reserve officials.
U.S. stock futures point lower and European stocks decline; Carl Icahn buys more Herbalife shares; FDA issues emergency use authorization for Roche Zika test.
U.S. stock futures are trading flat Monday as investors continue to digest comments from top Federal Reserve officials on Friday.
Food and health care companies were among the top stocks chosen in the quarter by the top PE firms.
Both firms snapped up a wide variety of stocks in the second quarter, according to their filings to the SEC.
It's apparently not all doom and gloom in the private-equity realm of stock picking these days.
Clearlake Capital Group, L.P.
Private equity firms are cutting their stakes in some companies amid perceived overvaluations in the market.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Stocks with insider trader activity include FII, HABT and CG
Carlyle (CG) could make two acquisitions in Japan worth $2 billion each.
Server and storage provider faces cloud competition, but may be takeover bait.
Adopt the private equity mindset by investing in CG when it is cheap.
The firm's latest earnings report is chock full of good advice.
Don't buy the shares, invest in puts and other instruments instead.
A source familiar with the matter said that TSG Consumer Partners earned 25 times its 2013 minority investment in the makeup company.
Biogen's announcement that CEO George Scangos would step down as head of the biotech company marks the latest company to see its chief leave the perch this year.